From Jeff Passan and Tim Brown of Yahoo! Sports:
Milwaukee Brewers star Ryan Braun’s name is in records of the Miami-area clinic alleged to have distributed performance-enhancing drugs to a rash of baseball players, and Major League Baseball will investigate the link to the former MVP who tested positive for illegal synthetic testosterone during the 2011 postseason.
Braun was cleared of that 2011 positive test due to what was perceived to be an error in the handling of his urine sample. His name is not listed next to any specific PED transactions in the Biogenesis records, but Major League Baseball will investigate the matter in the hope of learning about the outfielder’s exact level of involvement.
Yankees catcher Francisco Cervelli and Orioles third baseman Danny Valencia were also discovered in the records at the Biogenesis clinic but, like Braun, were not listed in connection with a specific PED.
UPDATE, 11:21 PM: Braun says in a written statement that he used Bosch for consulting in his successful PED appeal and that he has “nothing to hide” —
“During the course of preparing for my successful appeal last year, my attorneys, who were previously familiar with Tony Bosch, used him as a consultant. More specifically, he answered questions about T/E ratio and possibilities of tampering with samples. There was a dispute over compensation for Bosch’s work, which is why my lawyer and I are listed under ‘moneys owed’ and not on any other list. I have nothing to hide and have never had any other relationship with Bosch. I will fully cooperate with any inquiry into this matter.”
LAKE BUENA VISTA, Fla. — Orioles third baseman Manny Machado will become a free agent after the 2018 season and there has been no suggestion that the O’s and their young star have worked on a contract extension, strongly suggesting that Machado will test the open market next offseason.
While the Orioles have not said much about keeping him or trading him, yesterday considerable chatter filtered out here at the Winter Meetings suggests that they are serious about trading him now in order to get more than a draft pick in return when he eventually leaves Baltimore.
Jon Heyman reported yesterday that the Cardinals were a possible landing spot, and others have speculated that, at the moment, they’re the frontrunners for his services. Buster Olney, in a development that would make people go insane, I suspect, that the Yankees have expressed interest. It seems highly unlikely, though, that the Orioles would trade Machado within the division. Even if they did, they’d likely expect a premium from the Yankees that they would be unwilling to pay, especially given that they could easily wait Machado out until he was a free agent next year and give up nothing but cash for him. A couple of days ago we noted that the Phillies had expressed interest and the Orioles were doing their due diligence with respect to their farm system.
As far as the possible parameters of a deal, Ken Rosenthal reported that the O’s hope to acquire at least two controllable young starters in return. That’s a high price for a one-year Machado rental, but it makes sense for the Orioles to ask it. For Machado’s part, he reportedly wants to return to his original position, shortstop. He does not have no-trade protection, of course, so that may be a wish that is not fulfilled.
Machado had a down 2017, hitting .259/.310/.471, but still hit 33 homers and drove in 95 runs. In the two years prior, however, he posted OPSs of .876 and .861, and he’s still just 25. All of which is to say that the price for a team to acquire him will be high, even if he’s entering his walk year.